Emildap M 10mg/500mg Tablet ER
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Emildap M 10mg/500mg Tablet ER
Diabexe Duo 10mg/500mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This treatment effectively lowers elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to heart health protection. Diabexe Duo 10mg/500mg ER tablets can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinue only under their guidance, as cessation may elevate blood sugar, potentially causing kidney damage, blindness, and other serious issues. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as prescribed. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, cephalgia, nausea, emesis, and diarrhea. Hydration is crucial to avoid dehydration. Genital fungal infections are a possibility; diligent hygiene can reduce this risk. Prior to use, disclose any kidney or liver impairment, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before commencing treatment. Limit alcohol consumption, as it may exacerbate side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Emildap M 10mg/500mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Emildap M 10mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Emildap M 10mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Emildap M 10mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Emildap M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Emildap M 10mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Emildap M 10mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Emildap M 10mg/500mg Tablet ER works:
Emildap M, a 10mg/500mg extended-release tablet, combines dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin promotes glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action leads to improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Emildap M 10mg/500mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Emildap M 10mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Emildap M 10mg/500mg tablets may pose a risk to breastfeeding infants. Available evidence from human studies indicates potential transfer of the medication into breast milk, with a possibility of adverse effects on the nursing child.
DrivingCAUTION
Impaired driving is a possibility with either hypoglycemia or hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Emildap M 10mg/500mg Extended-Release tablets cautiously. Dosage modification of Emildap M 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Emildap M 10mg/500mg Extended-Release tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Emildap M 10mg/500mg Tablet ER :
Should you forget to take a scheduled Emildap M 10mg/500mg Extended-Release tablet, ingest it immediately upon remembrance. Nevertheless, if your next dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Emildap M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |


